Anders D Hove Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Anders D Hove.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Anders D Hove. Anders D Hove is Director in ARCA biopharma, Inc. ($ABIO) and Director in Trubion Pharmaceuticals, Inc ($TRBN) and Director in Anacor Pharmaceuticals, Inc. ($ANAC) and Director in Edge Therapeutics, Inc. ($EDGE).
Latest Insider Trading Transactions of Anders D Hove
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ANAC, ABIO, EDGE, TRBN
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 13 2021 | ABIO | ARCA biopharma, In ... | Hove Anders D | Director | Option Exercise | A | 4.31 | 12,000 | 51,720 | 12,000 | |
Mar 05 2018 | ABIO | ARCA biopharma, In ... | Hove Anders D | Director | Option Exercise | A | 0.72 | 8,000 | 5,760 | 8,000 | |
Feb 21 2017 | ABIO | ARCA biopharma, In ... | Hove Anders D | Director | Option Exercise | A | 2.50 | 10,000 | 25,000 | 10,000 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 69.40 | 4,096 | 284,262 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 14.22 | 15,000 | 213,300 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 5.11 | 15,000 | 76,650 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 5.20 | 12,500 | 65,000 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 6.74 | 15,000 | 101,100 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | D | 6.92 | 30,000 | 207,600 | 0 | |
Jun 24 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | D | 99.25 | 33,886 | 3,363,186 | 0 | 33.9 K to 0 (-100.00 %) |
May 18 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 98.93 | 72,385 | 7,161,048 | 0 | 72.4 K to 0 (-100.00 %) |
May 18 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 99.41 | 199,865 | 19,868,580 | 72,385 | 272.3 K to 72.4 K (-73.41 %) |
May 18 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 100.60 | 81,631 | 8,212,079 | 272,250 | 353.9 K to 272.3 K (-23.07 %) |
Apr 15 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Buy | C | 31.05 | 257,647 | 7,999,939 | 353,881 | 96.2 K to 353.9 K (+267.73 %) |
Apr 11 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 71.40 | 400 | 28,560 | 96,234 | 96.6 K to 96.2 K (-0.41 %) |
Apr 11 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 70.05 | 3,868 | 270,953 | 96,634 | 100.5 K to 96.6 K (-3.85 %) |
Apr 11 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 75.57 | 6,820 | 515,387 | 100,502 | 107.3 K to 100.5 K (-6.35 %) |
Apr 11 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 74.13 | 200 | 14,826 | 107,322 | 107.5 K to 107.3 K (-0.19 %) |
Apr 11 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 73.29 | 2,272 | 166,515 | 107,522 | 109.8 K to 107.5 K (-2.07 %) |
Apr 11 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 72.15 | 13,000 | 937,950 | 109,794 | 122.8 K to 109.8 K (-10.59 %) |
Apr 11 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 71.44 | 99,981 | 7,142,643 | 122,794 | 222.8 K to 122.8 K (-44.88 %) |
Apr 11 2016 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 70.33 | 102,760 | 7,227,111 | 222,775 | 325.5 K to 222.8 K (-31.57 %) |
Dec 17 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 111.25 | 900,000 | 100,125,000 | 325,535 | 1.2 M to 325.5 K (-73.44 %) |
Dec 15 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 117.36 | 40,000 | 4,694,400 | 33,886 | 73.9 K to 33.9 K (-54.14 %) |
Nov 12 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Buy | J | 0.00 | 73,092 | 0 | 73,886 | 794 to 73.9 K (+9,205.54 %) |
Nov 12 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | J | 0.00 | 372,982 | 0 | 1,225,535 | 1.6 M to 1.2 M (-23.33 %) |
Nov 12 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | S | 103.60 | 100,295 | 10,390,562 | 1,598,517 | 1.7 M to 1.6 M (-5.90 %) |
Nov 05 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Buy | J | 0.00 | 372,982 | 0 | 1,598,517 | 1.2 M to 1.6 M (+30.43 %) |
Nov 05 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Sell | J | 0.00 | 1,500,000 | 0 | 1,225,535 | 2.7 M to 1.2 M (-55.04 %) |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | Hove Anders D | Director | Option Exercise | C | 0.00 | 2,150,538 | 0 | 0 | |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | Hove Anders D | Director | Buy | J | 8.60 | 46,665 | 401,319 | 2,068,582 | 2 M to 2.1 M (+2.31 %) |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | Hove Anders D | Director | Buy | P | 11.00 | 450,000 | 4,950,000 | 2,021,917 | 1.6 M to 2 M (+28.63 %) |
Oct 08 2015 | EDGE | Edge Therapeutics, ... | Hove Anders D | Director | Buy | C | 0.00 | 1,571,917 | 0 | 1,571,917 | 0 to 1.6 M |
Jun 11 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | A | 69.40 | 4,096 | 284,262 | 4,096 | |
Jun 11 2015 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Grant | A | 0.00 | 794 | 0 | 794 | 0 to 794 |
May 28 2009 | TRBN | Trubion Pharmaceut ... | Hove Anders D | Director | Option Exercise | A | 2.28 | 5,000 | 11,400 | 5,000 | |
May 29 2008 | TRBN | Trubion Pharmaceut ... | Hove Anders D | Director | Option Exercise | A | 6.63 | 5,000 | 33,150 | 5,000 | |
May 30 2007 | TRBN | Trubion Pharmaceut ... | Hove Anders D | Director | Option Exercise | A | 19.08 | 5,000 | 95,400 | 5,000 | |
Oct 25 2006 | TRBN | Trubion Pharmaceut ... | Hove Anders D | Director | Option Exercise | C | 0.00 | 36,450 | 0 | 0 | |
Oct 25 2006 | TRBN | Trubion Pharmaceut ... | Hove Anders D | Director | Option Exercise | C | 0.00 | 1,483,474 | 0 | 0 | |
Oct 25 2006 | TRBN | Trubion Pharmaceut ... | Hove Anders D | Director | Option Exercise | C | 0.00 | 302,527 | 0 | 0 | |
Oct 25 2006 | TRBN | Trubion Pharmaceut ... | Hove Anders D | Director | Option Exercise | A | 13.78 | 12,500 | 172,250 | 12,500 | |
Oct 25 2006 | TRBN | Trubion Pharmaceut ... | Hove Anders D | Director | Buy | P | 13.00 | 704 | 9,152 | 37,154 | 36.5 K to 37.2 K (+1.93 %) |
Oct 25 2006 | TRBN | Trubion Pharmaceut ... | Hove Anders D | Director | Buy | C | 0.00 | 36,450 | 0 | 36,450 | 0 to 36.5 K |
Oct 25 2006 | TRBN | Trubion Pharmaceut ... | Hove Anders D | Director | Buy | P | 13.00 | 28,637 | 372,281 | 1,512,111 | 1.5 M to 1.5 M (+1.93 %) |
Oct 25 2006 | TRBN | Trubion Pharmaceut ... | Hove Anders D | Director | Buy | C | 0.00 | 1,483,474 | 0 | 1,483,474 | 0 to 1.5 M |
Oct 25 2006 | TRBN | Trubion Pharmaceut ... | Hove Anders D | Director | Buy | P | 13.00 | 5,840 | 75,920 | 308,367 | 302.5 K to 308.4 K (+1.93 %) |
Oct 25 2006 | TRBN | Trubion Pharmaceut ... | Hove Anders D | Director | Buy | C | 0.00 | 302,527 | 0 | 302,527 | 0 to 302.5 K |
Page: 1